Literature DB >> 17878198

Relapse of chronic inflammatory demyelinating polyneuropathy 5 years after autologous stem cell transplantation.

M Vermeulen1, M H J van Oers.   

Abstract

We describe relapse of chronic inflammatory demyelinating polyneuropathy in a patient who had been in remission for 5 years after treatment with autologous stem cell transplantation. Before the transplant, he needed higher doses of immunosuppressive treatment than are now necessary to maintain his improved condition. He now receives intravenous immunoglobulins at monthly intervals.

Entities:  

Mesh：

Year:  2007        PMID： 17878198      PMCID： PMC2117563          DOI： 10.1136/jnnp.2007.118240

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


  4 in total

1.  Successful autologous stem cell transplantation in a patient with chronic inflammatory demyelinating polyneuropathy.

Authors:  M Vermeulen; M H Van Oers
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-01       Impact factor: 10.154

2.  Clinical and MRI outcome after autologous hematopoietic stem cell transplantation in MS.

Authors:  A Saiz; Y Blanco; E Carreras; J Berenguer; M Rovira; T Pujol; P Marín; T Arbizu; F Graus
Journal:  Neurology       Date:  2004-01-27       Impact factor: 9.910

3.  Autologous stem cell transplantation in progressive multiple sclerosis--an interim analysis of efficacy.

Authors:  A Fassas; A Anagnostopoulos; A Kazis; K Kapinas; I Sakellari; V Kimiskidis; C Smias; N Eleftheriadis; V Tsimourtou
Journal:  J Clin Immunol       Date:  2000-01       Impact factor: 8.317

4.  High-dose therapy and autologous blood stem cell transplantation in POEMS syndrome.

Authors:  Arnaud Jaccard; Bruno Royer; Dominique Bordessoule; Jean-Claude Brouet; Jean-Paul Fermand
Journal:  Blood       Date:  2002-04-15       Impact factor: 22.113
  4 in total
  6 in total

Review 1.  Treatment of chronic inflammatory demyelinating polyneuropathy.

Authors:  Inna Kleyman; Thomas H Brannagan
Journal:  Curr Neurol Neurosci Rep       Date:  2015-07       Impact factor: 5.081

Review 2.  Immunomodulatory treatment other than corticosteroids, immunoglobulin and plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy.

Authors:  Mohamed Mahdi-Rogers; Ruth Brassington; Angela A Gunn; Pieter A van Doorn; Richard Ac Hughes
Journal:  Cochrane Database Syst Rev       Date:  2017-05-08

Review 3.  Newer therapeutic options for chronic inflammatory demyelinating polyradiculoneuropathy.

Authors:  Krista Kuitwaard; Pieter A van Doorn
Journal:  Drugs       Date:  2009-05-29       Impact factor: 9.546

Review 4.  Stem Cell Therapy in Neuroimmunological Diseases and Its Potential Neuroimmunological Complications.

Authors:  Franz Felix Konen; Philipp Schwenkenbecher; Konstantin Fritz Jendretzky; Stefan Gingele; Lea Grote-Levi; Nora Möhn; Kurt-Wolfram Sühs; Britta Eiz-Vesper; Britta Maecker-Kolhoff; Corinna Trebst; Thomas Skripuletz; Martin W Hümmert
Journal:  Cells       Date:  2022-07-11       Impact factor: 7.666

5.  Stem Cell Therapy for Neuropathic Pain: A Bibliometric and Visual Analysis.

Authors:  Houming Kan; Lijun Fan; Xiaodie Gui; Xiaoqiang Li; Sen Yang; Yuting Huang; Liping Chen; Wen Shen
Journal:  J Pain Res       Date:  2022-06-23       Impact factor: 2.832

Review 6.  Autologous haematopoietic stem cell transplantation for neurological diseases.

Authors:  Joachim Burman; Andreas Tolf; Hans Hägglund; Håkan Askmark
Journal:  J Neurol Neurosurg Psychiatry       Date:  2017-09-02       Impact factor: 10.154
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.